Template:Did you know nominations/Tomáš Cihlář
Appearance
- The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.
The result was: rejected by Yoninah (talk) 11:15, 21 June 2020 (UTC)
Issues raised in review unaddressed
DYK toolbox |
---|
Tomáš Cihlář
- ... that as a student, Czech American virologist Tomáš Cihlář, known today for developing hopeful anti-Covid-19 drug remdesivir, assisted Antonín Holý in developing tenofovir disoproxil, the primary drug used in the fight against HIV?[1][2]
- ALT1:... that Czech American virologist Tomáš Cihlář is credited with developing both tenofovir disoproxil to fight HIV and remdesivir to fight Covid-19?[1][2]
- Reviewed: Template:Did you know nominations
- Created/expanded by Swmmng (talk). Self-nominated at 13:12, 23 April 2020 (UTC).
@Swmmng: New and long enough, Earwig detects no copyvios. I'd like to see more specifics and better sourcing about Cihlář's involvement in developing remdesivir; these are generally large team efforts and simply saying he developed it himself isn't sufficient detail. Was he a laboratory scientist, a research group head, or was it in his executive position at Gilead? John P. Sadowski (NIOSH) (talk) 23:39, 21 May 2020 (UTC)
- The nominator hasn't edited since the 9th and has not responded to the comments left in the nomination or addressed the above issues; their last edit to the article (and their most recent edit on Wikipedia) did not give the necessary specifics requested above. Marking for closure as unsuccessful. Narutolovehinata5 tccsdnew 02:49, 21 June 2020 (UTC)
References
- ^ a b Anon., "Remdesivir Cleared For Use On Covid-19 Patients in Four Czech Hospitals", Prague Morning, April 29, 2020.
- ^ a b Saiver, F., "Je Remdesivir lékem na covid-19? O objevu týmu Tomáše Cihláře má být jasno už do konce dubna", Forbes, April 8, 2020.